You are here

Androgel

Public Citizen says FDA should add heart warning to popular testosterone drugs for men

Yahoo/AP

Tue, 02/25/14 - 07:27 am

Watson Pharmaceuticals

Endo Health Solutions

AbbVie is hit with 5 lawsuits citing the dangers of its 'low T' drug

Fierce Pharma

Fri, 02/7/14 - 10:52 am

Abbott sued on claims of Androgel danger, Bloomberg says

Yahoo/Fly on the Wall

Wed, 02/5/14 - 06:55 pm

Abbott Laboratories

New Research And Competition Could Hurt AbbVie's Other Blockbuster

Seeking Alpha

Thu, 11/21/13 - 02:05 pm

Testosterone Drugs Raise Heart Risk in $1 Billion Market

Bloomberg

Wed, 11/6/13 - 08:34 am

CVS shucking more drugs from its coverage list

Fierce Pharma

Fri, 11/9/12 - 11:26 am

pharmacy benefits

Bristol-Myers Squibb

United States : White & Case Secures Victory in AndroGel Antitrust Class Actions

equities.com

Sat, 10/13/12 - 12:48 pm

Par Pharmaceutical

Paddock Laboratories

Will Abbott's Magic Pill Send Stock Soaring?

Seeking Alpha

Mon, 09/24/12 - 05:56 pm

Testosterone marketing frenzy draws skepticism

Yahoo/AP

Sun, 09/9/12 - 11:20 am

Abbott Laboratories

Watson Pharmaceuticals

Testosterone Chases Viagra in Libido Race as Doctors Fret

Bloomberg

Thu, 05/3/12 - 11:11 am

Abbott Laboratories

FTC Loses Appeal in Androgel ‘Pay-for-Delay’ Patent Case

Bloomberg Businessweek

Thu, 04/26/12 - 09:26 am

Abbott Sues Generic Maker Teva Over Testosterone Drug Patent

Bloomberg

Mon, 05/2/11 - 12:31 pm

Teva Pharmaceuticals

Abbott Laboratories

Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone

Yahoo/PR NewsWire

Sat, 04/30/11 - 10:08 am

Abbott Laboratories

That's What You Call Product Differentiation?

Motley Fool

Fri, 12/31/10 - 10:53 am

Abbott Laboratories

The Lowdown On Low Testosterone And AndroGel

Pharmalot

Thu, 06/24/10 - 10:08 am

Abbott Laboratories

FTC loses pay-for-delay claim against Solvay

Fierce Pharma

Wed, 02/24/10 - 05:28 pm

Pages